POSTMENOPAUSAL BLEEDING CLINICAL GUIDELINE; RISK AND INVESTIGATION PROSPECTIVE STUDYPOSTMENOPAUSAL BLEEDING CLINICAL GUIDELINE; RISK AND INVESTIGATION PROSPECTIVE STUDY
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2019, Vol 8, Issue 8
Abstract
Postmenopausal uterine bleeding is defined as uterine bleeding after permanent cessation of menstruation resulting from loss of ovarian follicular activity. Bleeding can be spontaneous or related to ovarian hormone replacement therapy or to use of selective estrogen receptor modulators (eg, tamoxifen adjuvant therapy for breast carcinoma). Because anovulatory “cycles” with episodes of multimonth amenorrhea frequently precede menopause, no consensus exists regarding the appropriate interval of amenorrhea before an episode of bleeding that allows for the definition of postmenopausal bleeding. The clinician faces the possibility that an underlying malignancy exists, knowing that most often the bleeding comes from a benign source. Formerly, the gold-standard clinical investigation of postmenopausal uterine bleeding was institution-based dilation and curettage, but there now exist office-based methods for the evaluation of women with this complaint. Strategies designed to implement these diagnostic methods must be applied in a balanced way considering the resource utilization issues of overinvestigation and the risk of missing a malignancy with underinvestigation. Consequently, guidelines and recommendations were developed to consider these issues and the diverse spectrum of practitioners who evaluate women with postmenopausal bleeding. The guideline development group determined that, for initial management of spontaneous postmenopausal bleeding, primary asse sampling or transvaginal ultrasonography, allowing patients with an endometrial echo complex thickness of 4 mm or less to be managed expectantly. Guidelines are also provided for patients receiving selective estrogen receptor modulators or hormone replacement therapy, and for an endometrial echo complex with findings consistent with fluid in the endometrial cavity.ssment may be with either endometrial.
Authors and Affiliations
Dr. Liqaa Shaher Saleh
Keywords
Related Articles
- EP ID EP669048
- DOI -
- Views 118
- Downloads 0
INVERTASE ACTIVITY OF INTACT SACCHAROMYCES CEREVISIAE CELLS CULTURED IN SUGARCANE MOLASSES BY BATCH FERMENTATION PROCESS
Saccharomyces cerevisiae was cultured by batch fermentation in 2.6L of sugar cane molasses (supplemented with (NH4)2SO4, (5.1g/L), MgSO4.7H2O (75mg/L) and Na2HPO4.12H2O (2.4g/L); concentration of reducing sugars (RS) and...
CASE REPORT: IMPERFORATE HYMEN, AN EASILY MISSED DIAGNOSIS
Imperforate Hymen (IH) is a hereditary malformation that obstructs the female genital tract. It is found in 1 in 2000 female births. Hymenectomy or hymenotomy is the for IH treatment of choice. In some cultures and relig...
STUDY ON FRACTURE HEALING ACTIVITY OF ETHNOMEDICINAL PLANTS IN WESTERN NEPAL
Study on biological use of ethnomedicinal plant is of high interest in modern biological research. Researchers are interested in developing new sources of drug that can be from plant origin, which has been used locally b...
PRELIMINARY PHYTOCHEMICAL SCREENING AND ANTIOXIDANT ACTIVITIES OF VARIOUS EXTRACTS OF AERIAL PARTS OF ARTEMISIA CAMPESTRIS L. FROM ALGERIA
The objective of this work was to evaluate the preliminary phytochemical screening, total phenolics and antioxidant activities of three different extracts (Chloroforme, Ethyl acetate and Methanol) from the aerial parts o...
SPHERICAL CRYSTALLIZATION: A NOVEL TECHNIQUE IN DRUG PARTICLE DESIGNING
Spherical agglomeration is a modern technique where the drug crystals are converted to spherical form to improve compressibility, flowability and packability for the development of directly compressible pharmaceutical do...